2Feldman El, Stevens M J, Thomas PK, et al: A practical two - step quantitative clinical and electrophisialogical assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 1994,17 : 1281 - 1289.
3Ziegler D,Hanefeld M,Ruhau KJ,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti - oxidant alpha - lipoic acid. A 3 - week muhicenter randomized controlled trial ( ALADIN study ). Diabetowgia, 1995,38 : 1425 - 1433.
4Apfel SC, Asbury AK, Brilv. et al: positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trilas. J neurol Sci, 2001, 189:3 -5.
5Pfeifer MA, Ross DR. Sehrage JP. et al:Ahighly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care, 1993,16:1103 - 1115.
6Mendell JR, Sahenk Z:Clinical practice painful sensory neuropathy. N Engl J Med, 2003, 348:1243 - 1255.
7Sindrup SH, Jensen TS : Efficacy of pharmacological treatments of neuropathic pain : an update and effect related to mechanism of drug action. Pain, 1999,8:389 - 400.
8Dworkin RH, O'connor AB, Backonja M : pharmacologic management of neuropathic pain: evidence - based recommendations. Pain, 2007, 132:237 -251.
9Wong MC, Chung JWY, Wong TKS : Effects of treatments for symtoms of painful diabetic neuropathy: systemic review. BMJ, 2007,335 : 87 -96.
10Gilron I, Bailey JM, Tu D, et al : Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med, 2005. 352 : 1324 - 1334.
